Publications

An oncogenic role for ETV1 in melanoma.

Authors: Jané-Valbuena J, Widlund HR, Perner S, Johnson LA, Dibner AC, Lin WM, Baker AC, Nazarian RM, Vijayendran KG, Sellers WR, Hahn WC, Duncan LM, Rubin MA, Fisher DE, Garraway LA.

Cancer Research, 2010.

Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias.

Authors: Abdel-Wahab O, Manshouri T, Patel J, Harris K, Yao J, Hedvat C, Heguy A, Bueso-Ramos C, Kantarjian H, Levine RL, Verstovsek S.

Cancer Research, 2010.

Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP.

Authors: Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, Berninger P, Rothballer A, Ascano M Jr, Jungkamp AC, Munschauer M, Ulrich A, Wardle GS, Dewell S, Zavolan M, Tuschl T.

Cell, 2010.

Pro Isomerization in MLL1 PHD3-Bromo Cassette Connects H3K4me Readout to CyP33 and HDAC-Mediated Repression.

Authors: Wang Z, Song J, Milne TA, Wang GG, Li H, Allis CD, Patel DJ.

Cell, 2010.

Integrative analysis of the melanoma transcriptome.

Authors: Berger MF, Levin JZ, Vijayendran K, Sivachenko A, Adiconis X, Maguire J, Johnson LA, Robinson J, Verhaak RG, Sougnez C, Onofrio RC, Ziaugra L, Cibulskis K, Laine E, Barretina J, Winckler W, Fisher DE, Getz G, Meyerson M, Jaffe DB, Gabriel SB, Lander ES, Dummer R, Gnirke A, Nusbaum C, Garraway LA.

Genome Research, 2010.

Visible Fluorescence Detection of Type III Protein Secretion from Bacterial Pathogens.

Authors: Yount JS, Tsou LK, Dossa PD, Kullas AL, van der Velden AW, Hang HC.

Journal of the American Chemical Society, 2010.

RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF.

Authors: Poulikakos PI, Zhang C, Bollag G, Shokat KM, Rosen N.

Nature, 2010.

Disulfide-directed histone ubiquitylation reveals plasticity in hDot1L activation.

Authors: Chatterjee C, McGinty RK, Fierz B, Muir TW.

Nature Chemical Biology, 2010.

Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy.

Authors: Barretina J, Taylor BS, Banerji S, Ramos AH, Lagos-Quintana M, Decarolis PL, Shah K, Socci ND, Weir BA, Ho A, Chiang DY, Reva B, Mermel CH, Getz G, Antipin Y, Beroukhim R, Major JE, Hatton C, Nicoletti R, Hanna M, Sharpe T, Fennell TJ, Cibulskis K, Onofrio RC, Saito T, Shukla N, Lau C, Nelander S, Silver SJ, Sougnez C, Viale A, Winckler W, Maki RG, Garraway LA, Lash A, Greulich H, Root DE, Sellers WR, Schwartz GK, Antonescu CR, Lander ES, Varmus HE, Ladanyi M, Sander C, Meyerson M, Singer S.

Nature Genetics, 2010.

Foxo proteins cooperatively control the differentiation of Foxp3(+) regulatory T cells.

Authors: Ouyang W, Beckett O, Ma Q, Paik JH, Depinho RA, Li MO.

Nature Immunology, 2010.

Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers.

Authors: Chi P, Allis CD, Wang GG.

Nature Reviews. Cancer,  2010.

The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism.

Authors: Clower CV, Chatterjee D, Wang Z, Cantley LC, Vander Heiden MG, Krainer AR.

Proceedings of the National Academy of Sciences of the USA, 2010.